ONCODES.PREC.MED. EO-34 (ZR8) — Net Asset Momentum
ONCODES.PREC.MED. EO-34 (ZR8) recorded a net asset momentum of -111.6% as of December 2024, with net assets of €-429.39K EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See ONCODES.PREC.MED. EO-34 (ZR8) defensive interval to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
ONCODES.PREC.MED. EO-34 Net Asset Momentum (2021–2024)
This chart tracks ONCODES.PREC.MED. EO-34's year-over-year net asset growth across 4 annual reporting periods from 2021 to 2024. The most recent momentum reading is -111.6%, with net assets of €-429.39K EUR as of December 2024. Read ZR8 current and long-term liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for ONCODES.PREC.MED. EO-34 (2021–2024)
The table below shows the complete annual net asset history for ONCODES.PREC.MED. EO-34 from 2021 to 2024, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see ZR8 stock market capitalisation.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | €-429.39K | €10.71 Million | €11.14 Million | ▼ -111.6% |
| 2023 | €3.69 Million | €16.63 Million | €12.94 Million | ▼ -68.7% |
| 2022 | €11.78 Million | €18.37 Million | €6.59 Million | ▲ +180.5% |
| 2021 | €4.20 Million | €8.37 Million | €4.17 Million | — |